Arrowhead Pharmaceuticals
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $256,472 | $27,767 | $542,709 | $2,500 |
Gross Profit | 21,544 | 542,709 | 2,500 | |
EBITDA | -148,484 | 397,339 | -148,234 | |
EBIT | -154,707 | 391,255 | -153,469 | |
Net Income | -23,750 | -175,241 | 370,445 | -173,085 |
Net Change In Cash | 256,472 | 27,767 | 542,709 | 2,500 |
Free Cash Flow | 13,002 | -157,084 | 454,756 | -153,788 |
Cash | 88,706 | 129,793 | 185,709 | 53,889 |
Basic Shares | 135,702 | 139,039 | 134,484 | 124,848 |
Annual Financials
| Values in thousands | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 |
|---|---|---|---|---|
Revenue | $829,448 | $3,551 | $240,735 | $243,231 |
Gross Profit | 3,551 | 240,735 | 243,231 | |
EBITDA | 98,346 | -561,513 | -175,672 | -168,086 |
EBIT | -580,108 | -188,165 | -178,507 | |
Net Income | -1,631 | -599,493 | -205,275 | -176,494 |
Net Change In Cash | 829,448 | 3,551 | 240,735 | 243,231 |
Cost of Revenue | -76,362 | |||
Free Cash Flow | 156,886 | -604,320 | -330,627 | -188,908 |
Cash | 88,706 | 102,685 | 110,891 | 108,005 |
Basic Shares | 133,758 | 119,784 | 106,750 | 105,426 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | $0 |
2025-09-30 | -$0.18 |
2025-06-30 | -$1.26 |
2025-03-31 | $2.75 |
